CSL Ltd
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma produ… Read more
Market Cap & Net Worth: CSL Ltd (CSLLY)
CSL Ltd (PINK:CSLLY) has a market capitalization of $72.23 Billion ($72.23 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #589 globally and #471 in its home market, demonstrating a -5.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CSL Ltd's stock price $74.44 by its total outstanding shares 970302788 (970.30 Million).
CSL Ltd Market Cap History: 2015 to 2025
CSL Ltd's market capitalization history from 2015 to 2025. Data shows growth from $33.23 Billion to $72.23 Billion (10.57% CAGR).
CSL Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CSL Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.68x
CSL Ltd's market cap is 4.68 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
24.06x
CSL Ltd's market cap is 24.06 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $32.04 Billion | $4.41 Billion | $926.93 Million | 7.27x | 34.57x |
| 2017 | $49.37 Billion | $5.06 Billion | $1.02 Billion | 9.75x | 48.22x |
| 2018 | $58.94 Billion | $5.59 Billion | $1.27 Billion | 10.55x | 46.32x |
| 2019 | $88.73 Billion | $8.54 Billion | $1.92 Billion | 10.39x | 46.24x |
| 2020 | $101.02 Billion | $9.10 Billion | $1.46 Billion | 11.10x | 69.34x |
| 2021 | $98.71 Billion | $10.27 Billion | $1.78 Billion | 9.62x | 55.36x |
| 2022 | $92.19 Billion | $10.49 Billion | $2.25 Billion | 8.79x | 40.89x |
| 2023 | $93.61 Billion | $13.17 Billion | $2.19 Billion | 7.11x | 42.67x |
| 2024 | $89.12 Billion | $14.80 Billion | $2.64 Billion | 6.02x | 33.73x |
| 2025 | $72.23 Billion | $15.43 Billion | $3.00 Billion | 4.68x | 24.06x |
Competitor Companies of CSLLY by Market Capitalization
Companies near CSL Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to CSL Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
CSL Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, CSL Ltd's market cap moved from $33.23 Billion to $ 72.23 Billion, with a yearly change of 10.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $72.23 Billion | -18.95% |
| 2024 | $89.12 Billion | -4.80% |
| 2023 | $93.61 Billion | +1.55% |
| 2022 | $92.19 Billion | -6.61% |
| 2021 | $98.71 Billion | -2.29% |
| 2020 | $101.02 Billion | +13.86% |
| 2019 | $88.73 Billion | +50.53% |
| 2018 | $58.94 Billion | +19.40% |
| 2017 | $49.37 Billion | +54.07% |
| 2016 | $32.04 Billion | -3.56% |
| 2015 | $33.23 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of CSL Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $72.23 Billion USD |
| MoneyControl | $72.23 Billion USD |
| MarketWatch | $72.23 Billion USD |
| marketcap.company | $72.23 Billion USD |
| Reuters | $72.23 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.